Lamberts SW - Search Results

1

Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.

Hofland LJ, Lamberts SW, van Hagen PM, Reubi JC, Schaeffer J, Waaijers M, van Koetsveld PM, Srinivasan A, Krenning EP, Breeman WA. Hofland LJ, et al. Among authors: lamberts sw. J Nucl Med. 2003 Aug;44(8):1315-21. J Nucl Med. 2003. PMID: 12902423 Free article.

2

Somatostatin analogs in the diagnosis and treatment of cancer.

Lamberts SW, de Herder WW, Hofland LJ. Lamberts SW, et al. Trends Endocrinol Metab. 2002 Dec;13(10):451-7. doi: 10.1016/s1043-2760(02)00667-7. Trends Endocrinol Metab. 2002. PMID: 12431842 Review.

3

The pathophysiological consequences of somatostatin receptor internalization and resistance.

Hofland LJ, Lamberts SW. Hofland LJ, et al. Among authors: lamberts sw. Endocr Rev. 2003 Feb;24(1):28-47. doi: 10.1210/er.2000-0001. Endocr Rev. 2003. PMID: 12588807 Free article. Review.

4

Somatostatin receptors in malignant lymphomas: targets for radiotherapy?

Dalm VA, Hofland LJ, Mooy CM, Waaijers MA, van Koetsveld PM, Langerak AW, Staal FT, van der Lely AJ, Lamberts SW, van Hagen MP. Dalm VA, et al. Among authors: lamberts sw. J Nucl Med. 2004 Jan;45(1):8-16. J Nucl Med. 2004. PMID: 14734660 Free article.

5

Somatostatin receptors in pituitary function, diagnosis and therapy.

Hofland LJ, Lamberts SW. Hofland LJ, et al. Among authors: lamberts sw. Front Horm Res. 2004;32:235-52. doi: 10.1159/000079048. Front Horm Res. 2004. PMID: 15281350 Review.

6

Novel subtype specific and universal somatostatin analogues: clinical potential and pitfalls.

van der Hoek J, Hofland LJ, Lamberts SW. van der Hoek J, et al. Among authors: lamberts sw. Curr Pharm Des. 2005;11(12):1573-92. doi: 10.2174/1381612053764832. Curr Pharm Des. 2005. PMID: 15892663 Review.

7

The role of somatostatin analogs in Cushing's disease.

van der Hoek J, Lamberts SW, Hofland LJ. van der Hoek J, et al. Among authors: lamberts sw. Pituitary. 2004;7(4):257-64. doi: 10.1007/s11102-005-1404-x. Pituitary. 2004. PMID: 16132202 Review.

8

The somatostatin receptor subtype 5 in neuroendocrine tumours.

van der Hoek J, Lamberts SW, Hofland LJ. van der Hoek J, et al. Among authors: lamberts sw. Expert Opin Investig Drugs. 2010 Mar;19(3):385-99. doi: 10.1517/13543781003604710. Expert Opin Investig Drugs. 2010. PMID: 20151855 Review.

9

Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes.

Ferone D, Pivonello R, Van Hagen PM, Dalm VA, Lichtenauer-Kaligis EG, Waaijers M, Van Koetsveld PM, Mooy DM, Colao A, Minuto F, Lamberts SW, Hofland LJ. Ferone D, et al. Among authors: lamberts sw. Am J Physiol Endocrinol Metab. 2002 Nov;283(5):E1056-66. doi: 10.1152/ajpendo.00205.2001. Am J Physiol Endocrinol Metab. 2002. PMID: 12376335 Free article.

10

111In-octreotide scintigraphy in oncology.

Krenning EP, Kwekkeboom DJ, Reubi JC, Van Hagen PM, van Eijck CH, Oei HY, Lamberts SW. Krenning EP, et al. Among authors: lamberts sw. Metabolism. 1992 Sep;41(9 Suppl 2):83-6. doi: 10.1016/0026-0495(92)90038-c. Metabolism. 1992. PMID: 1355591 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

732 results

Search Page

Filters